These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22897695)

  • 21. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease.
    Alam ZI; Daniel SE; Lees AJ; Marsden DC; Jenner P; Halliwell B
    J Neurochem; 1997 Sep; 69(3):1326-9. PubMed ID: 9282961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease.
    Farkas E; De Jong GI; de Vos RA; Jansen Steur EN; Luiten PG
    Acta Neuropathol; 2000 Oct; 100(4):395-402. PubMed ID: 10985698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
    Winogrodzka A; Bergmans P; Booij J; van Royen EA; Stoof JC; Wolters EC
    J Neurol Neurosurg Psychiatry; 2003 Mar; 74(3):294-8. PubMed ID: 12588911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex network-driven view of genomic mechanisms underlying Parkinson's disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigra.
    Corradini BR; Iamashita P; Tampellini E; Farfel JM; Grinberg LT; Moreira-Filho CA
    Biomed Res Int; 2014; 2014():543673. PubMed ID: 25525598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.
    Knaryan VH; Samantaray S; Le Gal C; Ray SK; Banik NL
    J Neurochem; 2011 Aug; 118(3):326-38. PubMed ID: 21615738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease.
    Anglade P; Mouatt-Prigent A; Agid Y; Hirsch E
    Neurodegeneration; 1996 Jun; 5(2):121-8. PubMed ID: 8819132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.
    Jesse S; Kassubek J; Müller HP; Ludolph AC; Unrath A
    BMC Neurol; 2012 Dec; 12():163. PubMed ID: 23273141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
    Weintraub D; Dietz N; Duda JE; Wolk DA; Doshi J; Xie SX; Davatzikos C; Clark CM; Siderowf A
    Brain; 2012 Jan; 135(Pt 1):170-80. PubMed ID: 22108576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell transplantation in the damaged adult brain.
    Jaber M; Benoit-Marand M; Prestoz L; Gaillard A
    Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.
    Tong M; Dong M; de la Monte SM
    J Alzheimers Dis; 2009; 16(3):585-99. PubMed ID: 19276553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease.
    Corrigan FM; Murray L; Wyatt CL; Shore RF
    Exp Neurol; 1998 Apr; 150(2):339-42. PubMed ID: 9527905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of chemokines in Parkinson's disease.
    Liu JQ; Chu SF; Zhou X; Zhang DY; Chen NH
    Brain Res Bull; 2019 Oct; 152():11-18. PubMed ID: 31136787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine A(2A) receptor mRNA expression in Parkinson's disease.
    Hurley MJ; Mash DC; Jenner P
    Neurosci Lett; 2000 Sep; 291(1):54-8. PubMed ID: 10962152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging.
    Lisanby SH; McDonald WM; Massey EW; Doraiswamy PM; Rozear M; Boyko OB; Krishnan KR; Nemeroff C
    J Neural Transm Suppl; 1993; 40():13-21. PubMed ID: 8294897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.